Acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-248 -
Package NDC
62332-248-05 -
Package NDC
62332-248-15 -
Package NDC
62332-248-30 -
Application number
ANDA209000 -
SPL ID
40ce38dc-e259-49e3-98e4-0f529b9ab17e -
SPL set ID
5adf2205-5493-4e7a-bf50-01f4eb661dd8 -
UNII
X4HES1O11F -
RxCUI
197312
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- Acyclovir
- Form
- OINTMENT
- Routes
- CUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acyclovir",
"splId": "40ce38dc-e259-49e3-98e4-0f529b9ab17e",
"labels": [
{
"setId": "5adf2205-5493-4e7a-bf50-01f4eb661dd8",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5adf2205-5493-4e7a-bf50-01f4eb661dd8",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5adf2205-5493-4e7a-bf50-01f4eb661dd8"
}
],
"routes": [
"CUTANEOUS"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 TUBE in 1 CARTON (62332-248-05) / 5 g in 1 TUBE",
"package_ndc": "62332-248-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20250327"
},
{
"sample": false,
"description": "1 TUBE in 1 CARTON (62332-248-15) / 15 g in 1 TUBE",
"package_ndc": "62332-248-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20250327"
},
{
"sample": false,
"description": "1 TUBE in 1 CARTON (62332-248-30) / 30 g in 1 TUBE",
"package_ndc": "62332-248-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250327"
}
],
"productId": "62332-248_40ce38dc-e259-49e3-98e4-0f529b9ab17e",
"useDomain": "unknown",
"dosageForm": "OINTMENT",
"productNdc": "62332-248",
"deaSchedule": null,
"genericName": "Acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "50 mg/g"
}
],
"applicationNumber": "ANDA209000",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250327",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197312"
],
"spl_set_id": [
"5adf2205-5493-4e7a-bf50-01f4eb661dd8"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-248_40ce38dc-e259-49e3-98e4-0f529b9ab17e"